Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
During the past 12 months, D. Western Therapeutics Institute's average Book Value Per Share Growth Rate was 50.10% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -24.00% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -24.00% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was -12.20% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of D. Western Therapeutics Institute was 49.80% per year. The lowest was -36.30% per year. And the median was -3.70% per year.
During the past 13 years, the highest P/B Ratio of D. Western Therapeutics Institute was 13.51. The lowest was 2.56. And the median was 4.13.
D. Western Therapeutics Institute (TSE:4576) Book Value per Share Explanation
Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.
For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.
D. Western Therapeutics Institute Book Value per Share Related Terms
D. Western Therapeutics Institute Book Value per Share Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
D. Western Therapeutics Institute Book Value per Share Chart
TSE:4576 vs VRTX, REGN, RVMD: Book Value per Share Comparison
For the Biotechnology subindustry, D. Western Therapeutics Institute's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
D. Western Therapeutics Institute PB Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, D. Western Therapeutics Institute's PB Ratio distribution charts can be found below:
* The bar in red indicates where D. Western Therapeutics Institute's PB Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
D. Western Therapeutics Institute (TSE:4576) has a Book Value per Share of 円26.46 as of Dec. 2025. Book value per share gives the per-share value of a company's stockholder equity. View historical data on D. Western Therapeutics Institute and its competitors.
Is D. Western Therapeutics Institute's Book Value per Share too high?
D. Western Therapeutics Institute's current Book Value per Share is 円26.46. Overall, D. Western Therapeutics Institute has a GF Score™ of 47/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does D. Western Therapeutics Institute's Book Value per Share compare to VRTX and REGN?
D. Western Therapeutics Institute's Book Value per Share of 円26.46 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Book Value per Share for a Biotechnology company?
A good Book Value per Share depends on the Biotechnology industry context. However, Book Value per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Book Value per Share mean?
A high Book Value per Share can signal that a stock is expensive relative to its fundamentals. Book value per share gives the per-share value of a company's stockholder equity. View historical data on D. Western Therapeutics Institute and its competitors. D. Western Therapeutics Institute's current Book Value per Share is 円26.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is D. Western Therapeutics Institute stock overvalued right now?
Based on GuruFocus' analysis, D. Western Therapeutics Institute (TSE:4576) is currently considered Fairly Valued. The stock's GF Value™ is 円68.18, compared to a current price of 円75.00 — trading 10% above its estimated fair value. The current Book Value per Share is 円26.46. D. Western Therapeutics Institute's overall GF Score™ is 47/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Book Value per Share calculated?
Book Value per Share is calculated from a company's financial statements. For D. Western Therapeutics Institute (TSE:4576), the current Book Value per Share is 円26.46 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is D. Western Therapeutics Institute (TSE:4576) Overvalued in 2026?
Based on GuruFocus' analysis, D. Western Therapeutics Institute stock appears to be overvalued.
The current stock price of 円75.00 is trading 10% above its estimated GF Value™ of 円68.18.
GuruFocus considers D. Western Therapeutics Institute to be Fairly Valued.
Key valuation signals for TSE:4576:
Book Value per Share: 円26.46
GF Value™: 円68.18 vs. price of 円75.00 (10% above fair value)
No single metric tells the full story. See the TSE:4576 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
D. Western Therapeutics Institute Business Description
D. Western Therapeutics Institute Inc is engaged in the research and development of pharmaceutical drugs in Japan. Its products include ophthalmic solution and agents for antiplatelet and anti-glaucoma.
47GF Score
Get the complete analysis for TSE:4576
Book Value per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4576 has been successfully added to your 
